Lord, Abbett & Co
IRON icon

Lord, Abbett & Co’s Disc Medicine IRON Stock Holding History

Lord, Abbett & Co’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-119,312
Closed -$7.43M – 553
2024
Q1 		$7.43M Buy
+119,312
New +$7.74M 0.02% 431

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Lord, Abbett & Co's IRON Position: Q2 2024 in Review

Lord, Abbett & Co sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 119,312 shares — an estimated $7.43M sold.

Lord, Abbett & Co first reported a position in IRON in Q1 2024 and held it in 1 quarter. The position peaked at $7.43M in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Lord, Abbett & Co reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 119,312 Disc Medicine shares in Q2 2024, an estimated $7.43M.
  • Lord, Abbett & Co first reported a position in Disc Medicine in Q1 2024 and held it in 1 quarter.
  • Lord, Abbett & Co's Disc Medicine position peaked at $7.43M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Lord, Abbett & Co's 13F filing for Q2 2024, filed 14 Aug 2024.